Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia

被引:6
作者
Atadzhanov, M
Zumla, A
Mwaba, P
机构
[1] Univ Zambia, Sch Med, Univ Teaching Hosp, Dept Med, Lusaka, Zambia
[2] UCL, Windeyer Inst Med Sci, London, England
关键词
D O I
10.1136/pgmj.2004.018705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aims of this study were ( A) to determine inheritance patterns of familial Parkinson's disease in three different geographical areas ( Russia, Uzbekistan, and Zambia); ( B) compare clinical characteristics of familial with sporadic Parkinson's disease; and ( C) assess whether there were ethnic differences in clinical manifestations of the disease. Methods: Fifty two index cases of familial Parkinson's disease in Moscow, 55 in Tashkent, and 27 in Lusaka were selected on the basis of the typical clinical features of Parkinson's disease with a familial history. The sex ratio, transmission patterns, and segregation ratio were determined by pedigree analysis. Results: Familial Parkinson's disease was found in all three countries ( 30 families in Russia, 12 in Uzbekistan, and seven in Zambia), and appeared more common in Russia. Both autosomal dominant and autosomal recessive patterns of inheritance were seen, but autosomal dominance was more common in all countries. Conclusions: In all three countries men have a higher risk of developing Parkinson's disease than women and there are ethnic differences in clinical manifestations of the disease. The onset of both familial and sporadic Parkinson's disease in Zambian patients occurs at a younger age and is associated with slow progression and a benign course, and generally responds well to levodopa treatment.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 42 条
[11]   PARK3 influences age at onset in Parkinson disease:: A genome scan in the GenePD study [J].
DeStefano, AL ;
Lew, MF ;
Golbe, LI ;
Mark, MH ;
Lazzarini, AM ;
Guttman, M ;
Montgomery, E ;
Waters, CH ;
Singer, C ;
Watts, RL ;
Currie, LJ ;
Wooten, GF ;
Maher, NE ;
Wilk, JB ;
Sullivan, KM ;
Slater, KM ;
Saint-Hilaire, MH ;
Feldman, RG ;
Suchowersky, O ;
Lafontaine, AL ;
Labelle, N ;
Growdon, JH ;
Vieregge, P ;
Pramstaller, PP ;
Klein, C ;
Hubble, JP ;
Reider, CR ;
Stacy, M ;
MacDonald, ME ;
Gusella, JF ;
Myers, RH .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (05) :1089-1095
[12]   Familial aggregation of Parkinson's disease - A population-based case-control study in Europe [J].
Elbaz, A ;
Grigoletto, F ;
Baldereschi, M ;
Breteler, MM ;
Manubens-Bertran, JM ;
Lopez-Pousa, S ;
Dartigues, JF ;
Alperovitch, A ;
Tzourio, C ;
Rocca, WA .
NEUROLOGY, 1999, 52 (09) :1876-1882
[13]  
Gasser T, 2000, J NEURAL TRANSM-SUPP, P31
[14]  
GOLBE LI, 1990, NEUROLOGY, V40, P7
[15]   Clinical and genetic study of familial Parkinson's disease in Tunisia [J].
Gouider-Khouja, N ;
Belal, S ;
Ben Hamida, M ;
Hentati, F .
NEUROLOGY, 2000, 54 (08) :1603-1609
[16]   Neuroprotective effects of estrogens: potential mechanisms of action [J].
Green, PS ;
Simpkins, JW .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (4-5) :347-358
[17]  
GUNDMUNDSSON KR, 1967, ACTA NEUROL SCAND S, V33, P43
[18]  
Hawkes CH, 1997, BRIT J HOSP MED, V57, P130
[19]   Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations [J].
Hedrich, K ;
Marder, K ;
Harris, J ;
Kann, M ;
Lynch, T ;
Meija-Santana, H ;
Pramstaller, PP ;
Schwinger, E ;
Bressman, SB ;
Fahn, S ;
Klein, C .
NEUROLOGY, 2002, 58 (08) :1239-1246
[20]   Progress in the clinical and molecular genetics of familial parkinsonism [J].
Kitada, T ;
Asakawa, S ;
Matsumine, H ;
Hattori, N ;
Shimura, H ;
Minoshima, S ;
Shimizu, N ;
Mizuno, Y .
NEUROGENETICS, 2000, 2 (04) :207-218